Mori H, Sukegawa M, Fukatsu M, Sano T, Takahashi H, Harada K, Kimura S, Ohkawara H, Nakamura K, Mita M, Saito T, Hamazaki Y, Ohta M, Ikezoe T The link between interleukin-1β and acute myocardial infarction in chronic myeloid leukemia patients treated with nilotinib: cross-sectional study Annals of Hematology 99 (2), 359-361, 2020
Harada-Shirado K, Wang X, Mori H, Fukatsu M, Takahashi H, Shichishima-Nakamura A, Kimura S, Ohkawara H, Yamada S, Ito T, Ikezoe T Circulating intranuclear proteins may play a role in development of disseminated intravascular coagulation in individuals with acute leukemia International Journal of Hematology 111 (3), 378-387, 2020
Kimura S, Imagawa J, Murai K, Hino M, Kitawaki T, Okada M, Tanaka H, Shindo M, Kumagai T, Ikezoe T, Uoshima N, Sato T, Watanabe R, Kowata S, Hayakawa M, Hosoki T, Ikeda K, Kobayashi T, Kakinoki Y, Nishimoto T, Takezako N, Shibayama H, Takaori-Kondo A, Nakamae H, Kawaguchi A, Ureshino H, Sakamoto J, Ishida Y Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial The Lancet Haematology 7 (3), e218-e225, 2020
Han J, Jiang Z, Wang C, Chen X, Li R, Sun N, Liu X, Wang H, Hong L, Zheng K, Yang J, Ikezoe T Inhibition of Aurora-A promotes CD8⁺ T cell infiltration by mediating IL-10 production in cancer cells Molecular Cancer Research 18 (10), 1589-1602, 2020
Oriuchi N, Aoki M, Ukon N, Washiyama K, Tan C, Shimoyama S, Nishijima K, Takahashi K, Ito H, Ikezoe T, Zhao S Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using 211At-CXCR4 monoclonal antibody Scientific Report 10 (1), 6810, 2020
Kimura K, Ohkawara H, Minakawa K, Fukatsu M, Mori H, Takahashi H, Harada-Shirado K, Ohara Y, Takahashi N, Mochizuki K, Sano H, Kenenth E Nollet, Ogawa K, Ohto H, Kikuta A, Ikeda K, Ikezoe T Optimal timing of apheresis for the efficient mobilization of peripheral blood progenitor cells recruited by high-dose granulocyte colony-stimulating factor in healthy donors Transfusion and Apheresis Science 59 (3), 102737, 2020
Wada H, Honda G, Kawano N, Uchiyama T, Kawasugi K, Madoiwa S, Takezako N, Suzuki K, Seki Y, Ikezoe T, Iba T, Okamoto K Severe Antithrombin deficiency may be associated with a high risk of pathological progression of DIC with suppressed fibrinolysis Clinical and Applied Thrombosis/Hemostasis 26, 1-9, 2020
Miura S, Yoshihisa A, Misaka T, Yamaki T, Kojima T, Toyokawa M, Ogawa K, Shimura H, Yamamoto N, Kasahara K, Takeishi Y, Kitazume S Amyloid precursor protein 770 is specifically expressed and released from platelets Journal of Biological Chemistry 295 (38), 13194-13201, 2020
Mori J, Kaji S, Kawai H, Kida S, Tsubokura M, Fukatsu M, Harada K, Noji H, Ikezoe T, Maeda T, Matsuda A Assessment of dysplasia in bone marrow smear with convolutional neural network Scientific Reports 10 (1), 14734, 2020
The 25th International Congress of the European Hematology Association in Frankfurt (2020.6.11-6.14, Frankfurt, Germany WEB) Kiguchi T, Murayama K, Terui Y, Izutsu K, Ishizawa K, Nagai H, Usuki K, Suzumiya J, Kameoka Y, Hidaka M, Kato H, Matsumura I, Teshima T, Mitani K, Nakashima Y, Suehiro Y, Tsukamoto N, Ichikawa S, Kuroda J, Numata A, Komeno T, Fujisaki T, Ikezoe T, Imaizumi Y, Fukushima K, Tobinai K Single arm of bendamustine in combination with rituximab for relapsed or refractory diffuse large B-cell lymphoma in Japan
American Society of Human Genetics(ASHG) Virtual Meeting 2020 (2020.10.27-10.30, San Diego, America WEB) Wasserstein M, Arash-Kaps L, Barbato A, Renata C. Gallagher, Giugliani R, Norberto Bernardo Guelbert, Hollak C, Ikezoe T, Lachmann R, Lidove O, Mabe P, Mengel E, Scarpa M, Senates E, Tchan M, Villarrubia J, Chen Y, Fraser P, Beth L. Thurberg, Zaher A, Kumar M One-year results of the randomized ASCEND trial of olipudase alfa enzyme replacement therapy in adults with chronic acid sphingomyelinase deficiency shows significant visceral, pulmonary, and hematologic improvements in olipudase-alfa-treated but not placebo-treated patients
62th American Society of Hematology (ASH) Annual Meeting and Exposition第62回 米国血液学会 (2020.12.5-12.8, San Diego, America WEB) Suzuki K, Ashutosh D. Wechalekar, Kim K, Simazaki C, Jin Seok Kim, Ikezoe T, Chang-Ki Min, Zhou F, Iida S, Katoh N, Fujisaki T, Ho-Jin Shin, Tran N, Qin X, Sandra Y. Vasey, Tromp B, Brendan M. Weiss, Vermeulen J, Raymond L. Comenzo, Kastritis E, Lu J Subcutaneous daratumumab(DARA SC) + bortezomib, cyclophosphamide, and dexamethasone(VCd) in Asian patients with newly diagnosed light chain(AL) amyloidosis: subgroup analysis from the phase 3 andromeda study
62th American Society of Hematology (ASH) Annual Meeting and Exposition第62回 米国血液学会 (2020.12.5-12.8, San Diego, America WEB) Morita Y, Ikezoe T, Ando K, Onozawa M, Yamane T, Hosono N, Kiguchi T, Iwasaki H, Miyamoto T, Kasai M, Sugimoto S, Miyazaki Y, Kizaki M, Akashi K Phase 1 study of alvocidib (DSP-2033) in combination with cytarabine/mitoxantrone (ACM) or cytarabine/daunorubicin(A+7+3) in Japanese patients (Pts) with acute myeloid leukemia (AML)
62th American Society of Hematology (ASH) Annual Meeting and Exposition第62回 米国血液学会 (2020.12.5-12.8, San Diego, America WEB) Sugai M, Tsuyama N, Abe Y, Azami Y, Kudo K, Ota A, Sivasundarama K, Muramatsu M, Shigemura T, Sasatani M, Hashimoto Y, Kamiya K, Hanamura I, Ikezoe T, Onodera M, Sakai A Chromosomal translocation t(11;14) induced by the Cre-loxP system in normal B cell-derived iPS cells for the study of myeloma-initiating cells
